Table 2 Inclusion and exclusion criteria

Confirmed allergic rhinitis

Mental disorders

Sensitive to Artemisia pollen allergens

Systemic disease that the researchers consider to interfere with the study

Aged 18–65 years

Aged under 18 years or over 65 years

Provided informed consent and volunteered to participate in this clinical trial

Not cooperative during examination

Completed the case report form and other records

Employment changes leading to a possible loss to follow-up

Dysgnosia or behavioral disorders

The following conditions: nasal polyps, chronic sinusitis, severe nasal deviation, rhinitis medicamentosa, primary sleep disorders (> 1 night/week), obstructive sleep apnea, upper respiratory infection within 2 weeks prior to enrollment, or poorly controlled asthma

Pregnant or may become pregnant, or lactating with a positive urine pregnancy test

Drug abuse within the past 3 years

Must sleep in different bed more than six times in 3 weeks or for more than 3 consecutive nights

Smoked within the past 1 year

Sensitive to indoor allergens such as dust mites and pet dander

Other reasons, at the investigator’s discretion

Refusal to continue the trial because of a poor curative effect

Refusal to continue the trial for an unspecified reason

Loss to follow-up because of a change of address or telephone number

Loss to follow-up because of personal reasons